Foundation Medicine

Step 1: Submit tumor tissue sample for FoundationOne CDx testing.

Step 2: Foundation Medicine analyzes the sample and identifies an EGFR mutation.

Step 3: The report recommends treatment with an EGFR inhibitor.

Step 4: The oncologist prescribes the EGFR inhibitor, leading to improved patient outcomes.

Step 1: Submit tumor tissue sample for FoundationOne CDx testing.

Step 2: Foundation Medicine analyzes the sample and determines the TMB is high.

Step 3: The report indicates the patient may be a good candidate for immunotherapy.

Step 4: The oncologist prescribes an immune checkpoint inhibitor.

Step 1: Submit tumor tissue sample for FoundationOne CDx testing.

Step 2: Foundation Medicine identifies a rare gene fusion.

Step 3: The report includes a list of clinical trials targeting that specific fusion.

Step 4: The oncologist refers the patient to a clinical trial, providing access to cutting-edge therapies.

Step 1: Collect blood sample for FoundationOne Liquid CDx testing at baseline.

Step 2: Patient starts targeted therapy.

Step 3: Collect follow-up blood samples at regular intervals.

Step 4: Foundation Medicine analyzes the samples and monitors ctDNA levels to assess treatment response.

Step 1: Collect blood sample for FoundationOne Liquid CDx testing due to insufficient tissue.

Step 2: Foundation Medicine identifies a targetable mutation in the liquid biopsy.

Step 3: The report recommends a targeted therapy based on the liquid biopsy results.

Step 4: The oncologist prescribes the targeted therapy, improving patient outcomes.